Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 3, 2017 – Teligent announced the FDA approval of an AT-rated generic version of Aqua Pharmaceuticals’ Cordran (flurandrenolide) 0.05% ointment.
Return to publications